Literature DB >> 6244225

Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.

M J Lawman, B T Rouse, R J Courtney, R D Walker.   

Abstract

The conditions required for the induction of both primary cytotoxic T lymphocytes (CTL) in vivo and secondary CTL in vitro against herpes simplex virus type 1 (HSV-1)-infected cells were defined. Primary CTL responses occurred only in mice exposed to infectious HSV-1. These responses, which were shown to be mediated by T lymphocytes, peaked at 1 week and had disappeared by 2 weeks after infection. The level of primary cytotoxicity was enhanced by treatment of mice with cyclophosphamide before infection. Secondary in vitro CTL responses were more pronounced and were induced by some forms of inactivated virus as well as by infectious HSV-1. Thus, both ultraviolet light- and glutaraldehyde-inactivated preparations of HSV-1 induced CTL, but heat-inactivated and detergent-extracted antigens failed to do so. The reasons for the differing efficiency of infectious and noninfectious HSV-1 for induction of CTL are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244225      PMCID: PMC550735          DOI: 10.1128/iai.27.1.133-139.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Lysis of herpesvirus-infected cells by immune spleen cells.

Authors:  I A Ramshaw
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.

Authors:  K Pfizenmaier; A Starzinski-Powitz; M Röllinghoff; D Falks; H Wagner
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

5.  Immune mechanisms by which the spread of viral infections is stopped.

Authors:  A L Notkins
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

6.  The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo.

Authors:  R V Blanden; I D Gardner
Journal:  Cell Immunol       Date:  1976-03-15       Impact factor: 4.868

7.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus.

Authors:  T J Wiktor; P C Doherty; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

9.  Specifically immune mouse T-cells can destroy H-2 compatible murine target cells infected with herpes simplex virus types 1 or 2.

Authors:  K K Sethi; H Brandis
Journal:  Z Immunitatsforsch Immunobiol       Date:  1977-07

10.  Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.

Authors:  T J Braciale; K L Yap
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  42 in total

1.  Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

2.  Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor.

Authors:  D W Horohov; J H Wyckoff; R N Moore; B T Rouse
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.

Authors:  R Cappel; F de Cuyper; K De Neef; W Höbel; K Bolla
Journal:  Surv Immunol Res       Date:  1985

5.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Frequency of cytotoxic T lymphocyte precursors to herpes simplex virus type 1 as determined by limiting dilution analysis.

Authors:  B T Rouse; H S Larsen; H Wagner
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Role of Ia antigen expression and secretory function of accessory cells in the induction of cytotoxic T lymphocyte responses against herpes simplex virus.

Authors:  D S Schmid; H S Larsen; B T Rouse
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.